Hillgene Pharmaceutical Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
180
- Latest Deal Type
-
Series A1
- Investors
-
10
Hillgene Pharmaceutical General Information
Description
Provider of drug development, manufacturing and quality control services intended for cell drugs. The company's services include contract development and manufacturing, and it has built a special plasmid construction platform for cell drugs, a suspension serum-free virus production platform and a fully enclosed cell process development platform, enabling enterprises to maintain a complete, three-dimensional and strict quality assurance of the entire cell drugs process.
Contact Information
Website
www.hillgene.comCorporate Office
- Building 4, Yuewang Wisdom Valley, 1463 Wuzhong Avenue
- Wuzhong District
- Suzhou, Jiangsu 215100
- China
Corporate Office
- Building 4, Yuewang Wisdom Valley, 1463 Wuzhong Avenue
- Wuzhong District
- Suzhou, Jiangsu 215100
- China
Hillgene Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series A1) | 21-Aug-2023 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 16-Jan-2023 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 16-Jun-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 16-Mar-2022 | $15.8M | $15.8M | Completed | Generating Revenue | |
| 1. Early Stage VC | 08-Dec-2021 | Completed | Generating Revenue |
Hillgene Pharmaceutical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Hillgene Pharmaceutical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Hillgene Pharmaceutical Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Jiaxing Jiarui Investment Management | Growth/Expansion | Minority | ||
| Hangzhou Honghou Asset Management | Growth/Expansion | Minority | ||
| Suzhou Asset Management | Asset Manager | Minority | ||
| Suzhou Guofa Venture Capital | Venture Capital | Minority | ||
| Suzhou Tahoe Venture Capital | Venture Capital | Minority |
Hillgene Pharmaceutical FAQs
-
When was Hillgene Pharmaceutical founded?
Hillgene Pharmaceutical was founded in 2017.
-
Where is Hillgene Pharmaceutical headquartered?
Hillgene Pharmaceutical is headquartered in Suzhou, China.
-
What is the size of Hillgene Pharmaceutical?
Hillgene Pharmaceutical has 180 total employees.
-
What industry is Hillgene Pharmaceutical in?
Hillgene Pharmaceutical’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Hillgene Pharmaceutical a private or public company?
Hillgene Pharmaceutical is a Private company.
-
What is Hillgene Pharmaceutical’s current revenue?
The current revenue for Hillgene Pharmaceutical is .
-
How much funding has Hillgene Pharmaceutical raised over time?
Hillgene Pharmaceutical has raised $15.8M.
-
Who are Hillgene Pharmaceutical’s investors?
Jiaxing Jiarui Investment Management, Hangzhou Honghou Asset Management, Suzhou Asset Management, Suzhou Guofa Venture Capital, and Suzhou Tahoe Venture Capital are 5 of 10 investors who have invested in Hillgene Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
